Longevity for Women in Their 40s: The Biomarkers That Matter Most
In this article, we explore why your 40s are one of the most important decades for long-term health, especially for women. From hormones and blood sugar to cholesterol, inflammation, thyroid function and nutrient status, we’ll look at the key biomarkers that can reveal what is changing beneath the surface, helping you move from guesswork to clearer, data-led decisions about your health, energy and future wellbeing.
Your 40s aren’t the beginning of decline. They’re the window to get ahead of it.
For many women, the 40s arrive with a strange sense of biological unpredictability. You might be eating the same way, moving the same way, sleeping in the same bed, living inside the same body, and yet suddenly the rules feel different. Energy dips. Sleep becomes lighter. Periods become less predictable. Weight is harder to shift. Recovery takes longer. Brain fog appears like an unwanted browser tab. Mood, libido, skin, digestion and motivation can all begin to feel slightly less obedient than they once were.
The usual explanation is often vague: stress, hormones, age, life. Sometimes, that is partly true. But it is rarely the whole story.
Your 40s are one of the most important decades for long-term health because several biological systems can begin shifting at once. Hormones fluctuate. Cardiovascular risk starts to matter more. Blood sugar control can drift. Inflammation may become more relevant. Muscle and bone protection need more active attention. Thyroid function, iron stores, vitamin D, B12 and liver health can all affect how you feel day to day. This is not about panic. It is about visibility.
Longevity is not simply living to 100 while clutching a green juice and pretending to enjoy it. True longevity is about protecting the years where you still feel strong, clear, mobile, resilient and yourself. For women in their 40s, that starts with understanding the biomarkers that shape future health.
What does longevity mean for women in their 40s?
Longevity means extending healthy, functional years, not just total years lived. For women in their 40s, this means protecting cardiovascular health, metabolic health, hormone balance, bone strength, muscle mass, cognitive function, energy and resilience before preventable issues become harder to reverse. But your 40s are not a biological cliff edge. They are more like a control panel. The lights may start flashing differently, but that does not mean the machine is broken. It means it is asking for more intelligent maintenance.
In the UK, NHS Health Checks are offered to eligible adults aged 40 to 74 to help assess the risk of conditions such as heart disease, stroke, kidney disease and type 2 diabetes (NHS, 2023). That alone tells us something important: midlife is not too early to think about prevention. It is exactly when prevention starts becoming powerful.
The problem is that many women do not get a full picture. They might have one symptom investigated in isolation, while the wider pattern is missed. Tiredness might be treated as lifestyle. Weight gain might be treated as willpower. Anxiety might be treated as purely psychological. Irregular periods might be labelled “normal for your age”. Sometimes, the body is giving useful information, but nobody is reading the whole dashboard. That is where biomarkers matter.
What are biomarkers?
Biomarkers are measurable signs of what is happening inside your body. They can include blood markers such as cholesterol, HbA1c, thyroid hormones, vitamin D, ferritin, liver enzymes, kidney function markers, inflammation markers and reproductive hormones.
In simple terms, biomarkers help turn vague symptoms into clearer biological context. They do not replace medical advice or diagnosis, but they can help you understand patterns, spot early changes and make more targeted decisions about your health.
For women in their 40s, this matters because many midlife symptoms overlap. Fatigue, low mood, poor sleep, weight gain, hair thinning, low libido, cycle changes and brain fog can be influenced by multiple systems, including hormones, thyroid function, blood sugar, iron stores, vitamin D, inflammation and stress physiology.
Testing may not give you all the answers, but it gives you a much better starting point than guessing.
Why are your 40s such a high-leverage decade for health?
Your 40s are a high-leverage decade because hormonal, metabolic and cardiovascular changes often begin before obvious disease appears. This creates an opportunity to identify risk early, adjust lifestyle, track progress and protect long-term health.
Perimenopause can begin years before menopause. During this time, oestrogen and progesterone may fluctuate unevenly, which can affect sleep, mood, menstrual cycles, temperature regulation, energy, libido and body composition. NICE guidance states that menopause can usually be identified without laboratory tests in otherwise healthy women aged 45 or over with menopausal symptoms, while FSH testing may be considered in women aged 40 to 45 with menopause-associated symptoms or in younger women where menopause is suspected (NICE, 2024).
This distinction matters. Hormone testing should not be sold as a magic menopause detector for every woman over 40. The smarter approach is to use testing as part of a broader picture, especially when symptoms are confusing, cycles are changing, or you want to understand how hormones interact with thyroid, metabolic, inflammatory and nutrient markers.
At the same time, cardiovascular and metabolic risk can quietly increase. NICE recommends QRISK3 to estimate 10-year cardiovascular disease risk in adults aged 25 to 84 without established cardiovascular disease (NICE, 2023). NICE also recommends HbA1c or fasting plasma glucose testing for adults at high risk of type 2 diabetes (NICE, 2012).
In other words, your 40s are not too early to care about blood sugar, cholesterol, inflammation and organ function. They are exactly the decade where these markers start becoming deeply useful.
Which biomarkers should women in their 40s pay attention to?
The most useful biomarkers for women in their 40s fall into six key areas: cardiovascular health, metabolic health, hormone health, thyroid function, nutrient status, and inflammation or organ function.
These are not separate little islands floating around the body. They talk to each other constantly. Blood sugar affects inflammation. Oestrogen influences lipid metabolism. Thyroid hormones affect energy and weight regulation. Iron and B12 influence fatigue. Liver function affects hormone metabolism. Chronic stress can affect glucose, sleep, appetite and recovery.
The body is not a spreadsheet. It is an ecosystem with opinions.
Key biomarker areas for women in their 40s
|
Health area |
Key biomarkers |
Why they matter in your 40s |
|
Cardiovascular health |
Total cholesterol, LDL cholesterol, HDL cholesterol, non-HDL cholesterol, triglycerides, ApoB where available |
Helps assess long-term heart and vascular risk, especially as risk patterns can shift around midlife and menopause |
|
Metabolic health |
HbA1c, fasting glucose, insulin where available, triglycerides, liver enzymes |
Helps identify blood sugar drift, insulin resistance risk and early metabolic strain |
|
Hormone health |
Oestradiol, progesterone, FSH, LH, testosterone, SHBG, DHEA-S, prolactin, cortisol |
Helps build context around cycle changes, libido, energy, mood, stress and wider endocrine health |
|
Thyroid health |
TSH, free T4, free T3, thyroid antibodies where relevant |
Thyroid imbalance can mimic or worsen midlife symptoms such as fatigue, weight changes, mood issues and hair thinning |
|
Nutrient status |
Ferritin, vitamin D, active B12, folate, magnesium, zinc where available |
Nutrient gaps can affect energy, immunity, mood, muscle function, hair health and recovery |
|
Inflammation and organ function |
CRP or hs-CRP, full blood count, liver function, kidney function |
Helps assess background inflammation, anaemia patterns, infection clues, liver strain, kidney health and general physiological resilience |
Cardiovascular biomarkers: why cholesterol matters more than many women realise
Cardiovascular health is one of the most important longevity pillars for women in their 40s.
Heart disease is still too often framed as a male issue, but cardiovascular disease remains a major cause of illness and death among women. The British Heart Foundation continues to identify heart and circulatory diseases as a major health burden in the UK (British Heart Foundation, 2026).
For women in their 40s, the menopause transition is part of this conversation. Oestrogen is thought to have beneficial effects on blood vessels and lipid metabolism, and cardiovascular risk can become more important after menopause (Maas et al., 2021). This does not mean menopause causes heart disease in a simple one-step way. Biology is rarely that lazy. But it does mean midlife is an important moment to pay closer attention to cardiovascular risk markers.
The most common lipid markers include total cholesterol, LDL cholesterol, HDL cholesterol, non-HDL cholesterol and triglycerides. LDL cholesterol is often described as “bad” cholesterol because higher levels are associated with increased cardiovascular risk. HDL cholesterol is often called “good” cholesterol, although the reality is more nuanced. Non-HDL cholesterol can be particularly useful because it captures the cholesterol carried by several atherogenic particles, not just LDL.
ApoB, where available, can add further insight because it reflects the number of atherogenic lipoprotein particles. In practical terms, if cholesterol is the cargo, ApoB gives an idea of how many delivery vehicles are travelling through the bloodstream. More vehicles can mean more opportunity for cholesterol to enter artery walls.
For longevity, cholesterol testing is not about fear. It is about trajectory. A slightly raised marker in your 40s may be far easier to improve than a more entrenched cardiovascular risk pattern later.
Metabolic biomarkers: the quiet drift in blood sugar and insulin sensitivity
Metabolic health is one of the great under-discussed midlife issues for women.
Many women reach their 40s and notice that weight behaves differently. The same meals may feel less forgiving. Energy may rise and crash more sharply. Belly fat may become more stubborn. Cravings may intensify, especially after poor sleep or stress. This is not always a personal discipline issue. Often, it is metabolic physiology asking for attention.
HbA1c is one of the most useful markers here. It reflects average blood glucose over roughly the previous two to three months and is commonly used to assess diabetes risk and monitor diabetes. NICE recommends HbA1c or fasting plasma glucose testing for adults identified as high risk of type 2 diabetes (NICE, 2012).
Fasting glucose can show current blood sugar levels, while fasting insulin, if available, can give additional context around insulin resistance. Insulin resistance means the body needs to produce more insulin to move glucose out of the bloodstream and into cells. Over time, this can contribute to weight gain, energy dips, increased triglycerides, fatty liver risk and type 2 diabetes risk.
Triglycerides also matter. High triglycerides can reflect excess energy intake, alcohol intake, insulin resistance, poor metabolic flexibility or genetic factors. Liver markers such as ALT and GGT can also provide clues about metabolic strain, alcohol load, medication effects or fatty liver risk.
Metabolic health does not usually collapse overnight. It drifts. The earlier you spot the drift, the easier it is to change direction.
Hormone biomarkers: more than “am I menopausal?”
Hormones are often the first thing women think about in their 40s, and rightly so. But hormone health is bigger than menopause alone.
During perimenopause, oestrogen and progesterone can fluctuate unpredictably. Some months may feel completely normal, while others feel like the body has changed the Wi-Fi password without telling you. Symptoms can include irregular periods, heavier or lighter bleeding, night sweats, hot flushes, sleep disruption, mood changes, anxiety, low libido, vaginal dryness, breast tenderness, headaches and brain fog.
Key reproductive hormone markers may include oestradiol, progesterone, FSH and LH. Testosterone, SHBG and free androgen index may also be relevant, especially for libido, energy, muscle maintenance, mood and androgen-related symptoms. DHEA-S, prolactin and cortisol can add further endocrine context.
However, hormone results must be interpreted carefully. Hormones fluctuate across the menstrual cycle and can vary significantly from one day to another. A single hormone test is a snapshot, not the whole film. This is why symptoms, cycle history, age, medication use, contraceptive use and clinical context all matter.
NICE guidance is clear that menopause diagnosis in women aged 45 or over with typical symptoms is usually clinical, not dependent on routine blood tests (NICE, 2024). This is important because women deserve accurate information, not overpromised testing.
The real value of hormone testing in your 40s is context. It can help you understand patterns, investigate symptoms, explore whether thyroid or prolactin issues may be part of the picture, and support more informed conversations with healthcare professionals.
Thyroid biomarkers: the great symptom overlapper
Thyroid function deserves its own section because thyroid symptoms can overlap heavily with perimenopause and midlife stress.
An underactive thyroid can contribute to fatigue, low mood, weight gain, cold intolerance, constipation, dry skin, heavy periods, hair thinning and brain fog. An overactive thyroid can contribute to anxiety, palpitations, weight loss, heat intolerance, sweating, lighter periods and poor sleep.
The main thyroid markers include TSH, free T4 and sometimes free T3. Thyroid antibodies, such as thyroid peroxidase antibodies, can help identify autoimmune thyroid disease where relevant.
The reason thyroid testing matters for women in their 40s is not because every symptom is thyroid-related. It is because thyroid issues are common enough, and symptom overlap is messy enough, that ignoring thyroid function can leave a major blind spot.
If a woman is exhausted, gaining weight, losing hair, feeling low, sleeping poorly and experiencing cycle changes, it may be perimenopause. It may be thyroid dysfunction. It may be iron deficiency. It may be stress physiology. It may be several things at once, because the body enjoys making clean narratives difficult.
Testing helps separate the threads.
Nutrient biomarkers: small deficiencies can feel enormous
Nutrient markers are often treated as less important than hormones or cholesterol, but they can make an enormous difference to how a woman feels in her 40s.
Ferritin reflects stored iron. Low ferritin can contribute to fatigue, weakness, hair shedding, poor exercise tolerance, breathlessness, restless legs and reduced resilience. This is particularly relevant for women with heavy periods, which can become more common during perimenopause.
Vitamin B12 and folate are important for red blood cell production, nervous system function and energy metabolism. Low B12 can contribute to fatigue, tingling, numbness, cognitive symptoms and mood changes. Folate deficiency can also affect blood health and energy.
Vitamin D is important for bone and muscle health. NICE notes that UK vitamin D thresholds are used in relation to bone health, and deficiency increases health risk (NICE CKS, 2025). This becomes more relevant in midlife because women need to think actively about bone protection before fracture risk becomes an issue later. The National Osteoporosis Guideline Group highlights osteoporosis prevention and treatment particularly in postmenopausal women and men aged 50 and over (Gregson et al., 2025).
Magnesium and zinc, where available, may also provide useful context around muscle function, recovery, immunity, skin health and metabolic processes.
The simplest way to think about nutrient biomarkers is this: you cannot build energy, hormones, muscle, bone, neurotransmitters or resilience from missing raw materials.
Inflammation, liver and kidney biomarkers: the background operating system
Inflammation and organ function markers give insight into how the body is coping overall.
CRP or hs-CRP can indicate inflammation, although it is non-specific. Levels may rise with infection, injury, inflammatory conditions, obesity, smoking, poor sleep, chronic stress or other health issues. hs-CRP is sometimes used as part of cardiovascular risk assessment, although it should always be interpreted carefully and in context.
Liver function markers such as ALT, AST, GGT, ALP, bilirubin and albumin can help assess liver health, bile flow, alcohol-related strain, medication effects, metabolic stress and other issues. The liver is deeply involved in hormone metabolism, detoxification, glucose regulation and lipid metabolism, so it is not just an “organ function” marker. It is part of the whole longevity conversation.
Kidney markers such as creatinine, eGFR and urea help assess kidney function. Kidney health is relevant to blood pressure, cardiovascular risk, medication safety, hydration, metabolic health and long-term disease prevention.
A full blood count can also be useful because it looks at red blood cells, white blood cells and platelets. This can help identify patterns linked to anaemia, infection, immune activity and general blood health.
These markers are not glamorous, but they are foundational. Think of them as the backstage crew. If they are struggling, the whole show feels off.
Can biomarkers help with symptoms like tiredness, weight gain and brain fog?
Biomarkers can help identify possible biological contributors to symptoms such as tiredness, weight gain and brain fog, but they should be interpreted alongside symptoms, lifestyle, medication, menstrual history and clinical context.
For example, tiredness could be linked to low ferritin, low B12, thyroid dysfunction, poor blood sugar control, inflammation, poor sleep, high stress, perimenopause, liver strain or several overlapping factors. Weight gain could involve insulin resistance, thyroid changes, sleep disruption, stress, changing muscle mass, alcohol intake, reduced activity or hormonal shifts. Brain fog could involve sleep disturbance, low B12, thyroid imbalance, perimenopause, stress, low mood or glucose variability.
This is why single-cause thinking often fails women in midlife.
The body is not saying, “Here is one neat symptom from one neat cause.” It is usually giving a cluster of clues. Biomarker testing helps you move from “something feels off” to “these are the systems worth investigating first”.
How often should women in their 40s test their biomarkers?
Many women benefit from checking core health biomarkers once a year, although testing frequency depends on symptoms, risk factors, previous results, medication use and whether they are actively trying to improve specific markers.
For general prevention, annual testing can help track changes in cholesterol, HbA1c, liver function, kidney function, full blood count, thyroid markers and key nutrients. If a result is abnormal, borderline or changing quickly, a healthcare professional may recommend retesting sooner.
Women using HRT, managing thyroid issues, addressing nutrient deficiencies, improving cholesterol, changing diet, losing weight, training heavily or using certain medications may need more targeted monitoring.
The key is not to test obsessively. The key is to test intelligently.
A biomarker result is useful when it leads to better decisions: changing diet, increasing resistance training, improving sleep, reducing alcohol, addressing nutrient deficiencies, speaking to a clinician, tracking whether an intervention worked, or understanding whether symptoms need further investigation.
What lifestyle habits support longevity for women in their 40s?
The most powerful longevity habits for women in their 40s are resistance training, enough protein, fibre-rich nutrition, good sleep, alcohol moderation, stress management, cardiovascular exercise and regular health monitoring.
Resistance training is especially important because muscle mass supports glucose control, metabolic rate, bone strength, mobility and independence. Protein supports muscle maintenance and repair. Fibre supports gut health, cholesterol management, blood sugar control and satiety. Cardiovascular exercise supports heart, brain and metabolic health. Sleep influences appetite, glucose regulation, mood, hormones and recovery.
Alcohol deserves a more honest place in the midlife conversation too. Many women tolerate alcohol less well in their 40s, especially when sleep, stress and hormones are already shifting. Alcohol can affect liver markers, triglycerides, sleep quality, blood sugar regulation, mood and hot flushes.
None of this has to be extreme. You do not need to become a monk with a smartwatch. Longevity is built through consistent, unsexy, biologically sensible decisions repeated over time.
The magic is not in perfection. It is in feedback.
Where does Vitall fit in?
Most women do not need more vague advice. They need a clearer map.
Eat well. Move more. Lift weights. Sleep properly. Reduce alcohol. Manage stress. These are all sensible recommendations, but without testing, you may still be guessing which levers matter most for your body.
Vitall’s at-home health tests help women access biomarker-led health insights from home, with results designed to make key health markers easier to understand.
The Total Health Check gives a broad view of important markers linked to energy, metabolic health, cardiovascular risk, organ function, blood health, inflammation and nutrient status.
The Ultimate Female Hormones Check can support a deeper look at reproductive and endocrine markers, helping women build a wider picture around hormones, thyroid function, stress-related markers and midlife symptoms.
This is not about reducing women to numbers. It is about giving women more information, more context and more control.
Your 40s are not a warning sign. They are a window.
And the earlier you understand your data, the more options you have.
FAQs
What biomarkers should women check in their 40s?
Women in their 40s may benefit from checking cholesterol, HbA1c, liver function, kidney function, full blood count, thyroid markers, vitamin D, ferritin, B12, folate, inflammatory markers and relevant hormone markers. The most useful test depends on symptoms, personal risk factors, menstrual changes, family history and health goals.
Can a blood test tell if I am perimenopausal?
A blood test cannot reliably diagnose perimenopause in every woman because hormone levels fluctuate across the menstrual cycle and from month to month. NICE advises that menopause can usually be identified clinically in otherwise healthy women aged 45 or over with typical symptoms. FSH testing may be considered in women aged 40 to 45 with menopause-associated symptoms, or in younger women if premature ovarian insufficiency is suspected (NICE, 2024).
Why does cholesterol matter for women over 40?
Cholesterol matters because cardiovascular risk becomes increasingly important with age, and menopause-related hormonal changes may influence lipid patterns and vascular health. Testing cholesterol markers such as LDL, HDL, non-HDL cholesterol and triglycerides can help assess long-term cardiovascular risk and guide lifestyle or clinical action.
Why is HbA1c important in your 40s?
HbA1c reflects average blood glucose over roughly two to three months. It can help identify high blood sugar, diabetes risk or possible type 2 diabetes. In midlife, changes in insulin sensitivity, body composition, sleep, stress and activity levels can all influence metabolic health.
Are hormone tests useful for women in their 40s?
Hormone tests can be useful when interpreted in context. They may help build a picture around cycle changes, low libido, fatigue, mood changes, androgen symptoms, thyroid-related symptoms or suspected endocrine imbalance. However, they should not be treated as a standalone menopause diagnosis for every woman.
What is the best health test for women in their 40s?
The best health test depends on what you want to understand. A broad health check can assess cardiovascular, metabolic, nutrient, liver, kidney, blood and inflammatory markers. A female hormone test may be useful if symptoms suggest hormonal changes or endocrine imbalance. Many women benefit from looking at both general health and hormone markers together.
How often should women over 40 test their biomarkers?
Many women choose to test key biomarkers annually, especially if they are focused on prevention, longevity or health optimisation. More frequent testing may be useful when monitoring abnormal results, making lifestyle changes, taking medication, using HRT, correcting deficiencies or investigating symptoms.
What symptoms suggest women in their 40s should check their biomarkers?
Symptoms such as persistent fatigue, poor sleep, unexplained weight gain, brain fog, low mood, low libido, heavy or irregular periods, hair thinning, palpitations, poor recovery, night sweats, hot flushes or feeling generally “not right” may justify checking biomarkers. These symptoms can have multiple causes, so testing can help identify which systems need attention.
Get Yourself Tested With Vitall's Home Test Kits
Scientific review
Dr. Kate Bishop
Chief Scientific Officer - Vitall|Profile
Reviewed on 25/06/2026
Next review due 25/06/2027
Review focus: Blood biomarkers, laboratory testing methodology, and biochemical interpretation.
More Articles in These Categories
Similar Articles
View all articles ›Cholesterol: The Good & The Bad
What Do My Cholesterol Test Results Mean?
Cardiovascular Disease - Know Your Risk
"Finding Out I Had The Early Menopause Was Just Awful"
120,000+ UK People Die From Cardiovascular Disease A Year!
All About Your Liver Function
How Can I Keep My Liver Healthy?
How Nutritional Deficiencies Impact Anxiety and Mental Health
UK Statistics On Vitamin & Mineral Deficiency 2023
Six Ways To Reduce Your Inflammation
References & Citations For Longevity for Women in Their 40s: The Biomarkers That Matter Most
British Heart Foundation (2026) UK cardiovascular disease statistics. London: British Heart Foundation.
Gregson, C.L., Armstrong, D.J., Bowden, J., Cooper, C., Edwards, J., Gittoes, N.J.L., Harvey, N., Javaid, M.K., Judge, A., Kanis, J.A., Leyland, S., Low, R., McCloskey, E., Moss, K., Parker, J., Paskins, Z., Poole, K.E.S., Reid, D.M., Stone, M.D. and Compston, J. (2025) ‘The 2024 UK clinical guideline for the prevention and treatment of osteoporosis’, Archives of Osteoporosis, 20, article 58.
Maas, A.H.E.M., Rosano, G., Cifkova, R., Chieffo, A., van Dijken, D., Hamoda, H., Kunadian, V., Laan, E., Lambrinoudaki, I., Maclaran, K., Panay, N., Stevenson, J.C., van Trotsenburg, M. and Collins, P. (2021) ‘Cardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions: a consensus document from European cardiologists, gynaecologists, and endocrinologists’, European Heart Journal, 42(10), pp. 967–984.
National Institute for Health and Care Excellence (2012) Type 2 diabetes: prevention in people at high risk. Public health guideline PH38. London: NICE.
National Institute for Health and Care Excellence (2023) Cardiovascular disease: risk assessment and reduction, including lipid modification. NICE guideline NG238. London: NICE.
National Institute for Health and Care Excellence (2024) Menopause: identification and management. NICE guideline NG23. London: NICE.
National Institute for Health and Care Excellence Clinical Knowledge Summaries (2025) Vitamin D deficiency in adults. London: NICE.
NHS (2023) NHS Health Check. London: NHS.
North American Menopause Society (2022) ‘The 2022 hormone therapy position statement of The North American Menopause Society’, Menopause, 29(7), pp. 767–794.
Santoro, N., Epperson, C.N. and Mathews, S.B. (2015) ‘Menopausal symptoms and their management’, Endocrinology and Metabolism Clinics of North America, 44(3), pp. 497–515.
Sattar, N., Gill, J.M.R. and Alazawi, W. (2020) ‘Improving prevention strategies for cardiometabolic disease’, Nature Reviews Endocrinology, 16(7), pp. 387–389.
World Health Organization (2021) Cardiovascular diseases. Geneva: World Health Organization











